| Thrombolysis for acute ischemic stroke. | |
| | |
MedLine Citation:
|
PMID: 19849662 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
In the last decennium, thrombolytic therapy has changed the management of acute ischemic stroke. Randomized clinical studies have demonstrated that intravenous thrombolysis with tissue plasminogen activator improves functional outcomes. Recently the time window for intravenous thrombolysis has been extended from 3 to 4.5 hours after stroke onset, which will allow more stroke patients to benefit from this treatment. Currently several studies are investigating how to improve recanalization rates of thrombolytic therapy. In this review several aspects of intravenous and intra-arterial thrombolysis are discussed. |
| | |
Authors:
|
M Uyttenboogaart; J De Keyser; G J Luijckx |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Current topics in medicinal chemistry Volume: 9 ISSN: 1873-4294 ISO Abbreviation: Curr Top Med Chem Publication Date: 2009 |
Date Detail:
|
Created Date: 2009-11-20 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101119673 Medline TA: Curr Top Med Chem Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 1285-90 Citation Subset: IM |
Affiliation:
|
Department of Neurology, University Medical Center Groningen, University of Groningen, the Netherlands. m.uyttenboogaart@neuro.umcg.nl |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Dyslipidemia as a Risk Factor for Ischemic Stroke.
Next Document: Blood Pressure as a Therapeutic Target in Stroke.